These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31828020)

  • 1. Differential improvement of negative-symptom subfactors after cognitive remediation in low-functioning individuals with schizophrenia.
    Sevy S; Lindenmayer JP; Khan A; Ljuri I; Kulsa MKC; Jones O
    Schizophr Res Cogn; 2020 Mar; 19():100145. PubMed ID: 31828020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cognitive performance and negative symptoms on psychosocial functioning in Czech schizophrenia patients.
    Kalisova L; Michalec J; Dechterenko F; Silhan P; Hyza M; Chlebovcova M; Brenova M; Bezdicek O
    Schizophrenia (Heidelb); 2023 Jul; 9(1):43. PubMed ID: 37460587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does social cognition training augment response to computer-assisted cognitive remediation for schizophrenia?
    Lindenmayer JP; Khan A; McGurk SR; Kulsa MKC; Ljuri I; Ozog V; Fregenti S; Capodilupo G; Buccellato K; Thanju A; Goldring A; Parak M; Parker B
    Schizophr Res; 2018 Nov; 201():180-186. PubMed ID: 29910120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits.
    Lindenmayer JP; Fregenti S; Kang G; Ozog V; Ljuri I; Khan A; Goldring A; McGurk SR
    Schizophr Res; 2017 Jul; 185():154-160. PubMed ID: 28094171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to cognitive remediation in service recipients with severe mental illness.
    Lindenmayer JP; Ozog VA; Khan A; Ljuri I; Fregenti S; McGurk SR
    Psychiatr Rehabil J; 2017 Mar; 40(1):61-69. PubMed ID: 28368180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia.
    Rek-Owodziń K; Tyburski E; Plichta P; Waszczuk K; Bielecki M; Wietrzyński K; Podwalski P; Rudkowski K; Michalczyk A; Grąźlewski T; Sagan L; Kucharska-Mazur J; Samochowiec J; Mak M
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder.
    McClure MM; Graff F; Triebwasser J; Perez-Rodriguez M; Rosell DR; Koenigsberg H; Hazlett EA; Siever LJ; Harvey PD; New AS
    Am J Psychiatry; 2019 Apr; 176(4):307-314. PubMed ID: 30654644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder.
    O'Reilly K; Donohoe G; O'Sullivan D; Coyle C; Corvin A; O'Flynn P; O'Donnell M; Galligan T; O'Connell P; Kennedy HG
    BMC Psychiatry; 2019 Jan; 19(1):27. PubMed ID: 30646884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized or manual? Long term effects of cognitive remediation on schizophrenia.
    Zhu X; Fan H; Zou Y; Tan Y; Yang F; Wang Z; Zhao Y; Fan F; Reeder C; Zhou D; Tan S; Wykes T
    Schizophr Res; 2022 Jan; 239():47-54. PubMed ID: 34839074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-perceptual deficits and symptom correlates in first-episode schizophrenia.
    Olivier RM; Kilian S; Chiliza B; Asmal L; Oosthuizen PP; Emsley R; Kidd M
    S Afr J Psychiatr; 2017; 23():1049. PubMed ID: 30263189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative Symptom Domains Are Associated With Verbal Learning in Adolescents With Early Onset Psychosis.
    Mørch-Johnsen L; Smelror RE; Andreou D; Barth C; Johannessen C; Wedervang-Resell K; Wortinger LA; Díaz R; Victoria G; Ueland T; Andreassen OA; Myhre AM; Rund BR; Ulloa RE; Agartz I
    Front Psychiatry; 2021; 12():825681. PubMed ID: 35069300
    [No Abstract]   [Full Text] [Related]  

  • 15. Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural Consistency.
    Khan A; Liharska L; Harvey PD; Atkins A; Ulshen D; Keefe RSE
    Innov Clin Neurosci; 2017 Dec; 14(11-12):30-40. PubMed ID: 29410935
    [No Abstract]   [Full Text] [Related]  

  • 16. A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective Disorder.
    Kantrowitz JT; Sharif Z; Medalia A; Keefe RS; Harvey P; Bruder G; Barch DM; Choo T; Lee S; Lieberman JA
    J Clin Psychiatry; 2016 Jun; 77(6):799-806. PubMed ID: 27035157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of experiential and expressive negative symptoms on job obtainment and work outcome in individuals with schizophrenia.
    Llerena K; Reddy LF; Kern RS
    Schizophr Res; 2018 Feb; 192():148-153. PubMed ID: 28599750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlations between hormone levels and psychiatric symptoms as well as cognitive function in drug-free first-episode schizophrenics].
    Yuan XX; Zhu QY; Liang HB; Hei GR; Li X; Pang LJ; Li HH; Li H; Song XQ
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2155-60. PubMed ID: 27464540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving social functioning in community-dwelling patients with schizophrenia: a randomized controlled computer cognitive remediation therapy trial with six months follow-up.
    Zhu X; Fan H; Fan F; Zhao Y; Tan Y; Yang F; Wang Z; Xue F; Xiao C; Li W; Li Z; Ma L; Zou Y; Tan S
    Psychiatry Res; 2020 May; 287():112913. PubMed ID: 32203751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
    Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A
    Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.